AbbVie Inc (BSP:ABBV34)
R$ 69.32 0 (0%) Market Cap: 1.97 Til Enterprise Value: 2.37 Til PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 80/100

Abbvie Inc at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 04:00PM GMT
Release Date Price: R$38.3 (-0.85%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Good afternoon, welcome to the UBS Global Healthcare Conference. My name is Navin Jacob, I cover smid-cap biotech and large-cap pharma here at UBS. I'm happy to have with me, for our next session, AbbVie Pharmaceuticals. And from AbbVie, we have Michael Severino, Vice Chairman and President; Rob Michael, SVP and CFO; Jeff Stewart, SVP and Head of Commercial Ops. Thank you, gentlemen, for joining me today. And we also have Liz Shea, Head of Investor Relations as well.

So we're -- this is going to be a Q&A fireside chat for the full 45 minutes. We do have an ability for our audience members to ask questions via this webcast, so if you do so, I will see those questions at the bottom of my screen. They are anonymous, so don't worry if you're shy and don't want to necessarily showcase who's coming -- who's asking the questions. Those are anonymous, and I will try and read those -- some of those questions out at the end of this session.

Thank you so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot